Transplantation ChimeraChimeraLiver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantation ImmunologyTransplantationCell TransplantationRadiation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicLiving DonorsTransplantation, HeterotopicTreatment OutcomeCord Blood Stem Cell TransplantationHeart-Lung TransplantationTransplantation ToleranceTissue and Organ ProcurementFetal Tissue TransplantationPeripheral Blood Stem Cell TransplantationTime FactorsSkin TransplantationImmunosuppressionLiver FailureRetrospective StudiesHistocompatibility TestingRecombinant Fusion ProteinsPostoperative ComplicationsTransplantation, HeterologousWaiting ListsRecurrenceHistocompatibilityTissue TransplantationMesenchymal Stem Cell TransplantationWhole-Body IrradiationCorneal TransplantationHematologic NeoplasmsTacrolimusCyclosporineFollow-Up StudiesCadaverSurvival RateBrain Tissue TransplantationSurvival AnalysisFacial TransplantationDonor SelectionLiver DiseasesMice, Inbred C57BLOrgan PreservationTransplantsBusulfanHLA AntigensLeukemiaKidney Failure, ChronicHematopoietic Stem CellsMolecular Sequence DataBronchiolitis ObliteransCombined Modality TherapyRisk FactorsT-LymphocytesAntilymphocyte SerumChimerismCell DifferentiationRemission InductionAcute DiseaseHand TransplantationAnemia, AplasticBone Marrow CellsBlood Group IncompatibilityCytomegalovirus InfectionsMycophenolic AcidPostoperative PeriodMyeloablative AgonistsLiverTissue and Organ HarvestingRats, Inbred LewCyclophosphamidePrognosisEnd Stage Liver DiseaseNeoplasm TransplantationAmino Acid SequenceGraft vs Leukemia EffectPatient SelectionLymphocyte TransfusionStem CellsDisease-Free Survival